tiprankstipranks
Artelo Biosciences Inc (ARTL)
NASDAQ:ARTL
US Market
Holding ARTL?
Track your performance easily

Artelo Biosciences (ARTL) Financial Statements

468 Followers

Artelo Biosciences Financial Overview

Artelo Biosciences's market cap is currently ―. The company's EPS TTM is $-2.844; its P/E ratio is -0.33; Artelo Biosciences is scheduled to report earnings on March 26, 2025, and the estimated EPS forecast is $-0.44. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -1.13M$ -2.43M$ -2.48M$ -3.07M$ -2.45M
EBITDA$ -1.13M$ -2.43M$ -2.48M$ -3.07M$ -2.45M
Net Income Common Stockholders$ -1.13M$ -2.43M$ -2.48M$ -3.07M$ -2.45M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 500.00K$ 4.72M$ 6.41M$ 7.61M$ 10.22M
Total Assets$ 7.14M$ 8.33M$ 10.35M$ 13.04M$ 15.50M
Total Debt$ 112.00K$ 120.00K$ 127.00K$ 23.00K$ 32.00K
Net Debt$ -388.00K$ -4.60M$ -6.29M$ -7.59M$ -10.19M
Total Liabilities$ 775.00K$ 1.03M$ 817.00K$ 1.29M$ 921.00K
Stockholders Equity$ 6.36M$ 7.30M$ 9.54M$ 11.75M$ 14.58M
Cash Flow-
Free Cash Flow$ -778.00K$ -2.06M$ -2.94M$ -2.60M$ -1.80M
Operating Cash Flow$ -778.00K$ -2.06M$ -2.94M$ -2.60M$ -1.80M
Investing Cash Flow$ 4.25M$ 1.75M$ 1.27M$ 2.74M$ -1.83M
Financing Cash Flow--$ 55.00K$ 32.00K$ 535.00K
Currency in USD

Artelo Biosciences Earnings and Revenue History

Artelo Biosciences Debt to Assets

Artelo Biosciences Cash Flow

Artelo Biosciences Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis